Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23210)

• Formulation Name: Lifitegrast 50 mg/ml solution
• Company: Novartis Pharmaceuticals Corporation

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
lifitegrast	(DM4WVC5)	Dry eye disease	9E1Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Disodium hydrogenorthophosphate	(E00283)	24203	Buffering agent; Complexing agent
Hydrochloric acid	(E00015)	313	Acidulant
Sodium chloride	(E00077)	5234	Diluent; Tonicity agent
Sodium hydroxide	(E00234)	14798	Alkalizing agent
Sodium thiosulfate	(E00300)	24477	Antioxidant
Water	(E00035)	962	Solvent